Sagittarius Life Science Corp (TPEX:3205)

Sagittarius Life Science Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	141.14	83.79	133.89	189.48	255.66	394.24
Short-Term Investments	-	77.11	81.49	80.24	99.25	-
Cash & Short-Term Investments	141.14	160.9	215.38	269.72	354.91	394.24
Cash Growth	-25.65%	-25.30%	-20.14%	-24.00%	-9.98%	-24.55%
Accounts Receivable	37.55	52.03	50.36	47.15	53.68	63.53
Other Receivables	-	-	-	-	-	5.16
Receivables	37.55	52.03	50.36	47.15	53.68	68.69
Inventory	19.2	31.05	31.54	27.94	28.57	32.88
Prepaid Expenses	-	-	-	-	-	4.55
Other Current Assets	686.35	6.84	35.59	29.81	10.98	7.01
Total Current Assets	884.23	250.82	332.87	374.61	448.15	507.37
Property, Plant & Equipment	100.47	109.61	114.2	118.42	128.83	145.09
Long-Term Investments	154.23	152.82	210.57	79.14	81.87	67.64
Other Intangible Assets	-	0.43	0.01	0.07	0.23	0.32
Other Long-Term Assets	5.85	6.14	7.08	6.89	16.68	20.33
Total Assets	1,145	519.83	664.72	579.12	675.75	740.74
Accounts Payable	56.41	61.11	65.08	78.44	83.67	58.86
Current Portion of Leases	3.85	6.59	7.07	8.01	10.56	15.75
Current Income Taxes Payable	-	-	-	-	0.01	0.49
Current Unearned Revenue	-	0.44	0.67	1.41	-	-
Other Current Liabilities	20.91	23.86	54.3	28.55	31.69	50.68
Total Current Liabilities	81.17	92	127.13	116.4	125.94	125.77
Long-Term Leases	1.54	4.18	6.25	3.36	13.44	21.89
Other Long-Term Liabilities	3.89	3.89	4.44	3.94	4.66	4.69
Total Liabilities	86.6	100.07	137.82	123.71	144.03	152.36
Common Stock	675.46	325.46	325.46	325.46	327.73	327.73
Additional Paid-In Capital	370.41	89.71	144.75	222.92	309.24	405.12
Retained Earnings	-31.43	-48.53	-55.04	-79.6	-86.42	-99.03
Treasury Stock	-	-	-	-	-8.74	-8.74
Comprehensive Income & Other	40.6	41.72	99.49	-26.99	-25.03	-38.85
Total Common Equity	1,055	408.35	514.65	441.79	516.78	586.22
Minority Interest	3.14	11.41	12.25	13.62	14.94	2.16
Shareholders' Equity	1,058	419.76	526.9	455.42	531.71	588.38
Total Liabilities & Equity	1,145	519.83	664.72	579.12	675.75	740.74
Total Debt	5.39	10.77	13.32	11.37	24	37.64
Net Cash (Debt)	135.75	150.14	202.06	258.35	330.91	356.6
Net Cash Growth	-22.76%	-25.70%	-21.79%	-21.93%	-7.20%	-27.17%
Net Cash Per Share	3.73	4.61	6.21	7.94	10.17	10.93
Filing Date Shares Outstanding	47.69	32.55	32.55	32.55	32.55	32.55
Total Common Shares Outstanding	47.69	32.55	32.55	32.55	32.55	32.55
Working Capital	803.06	158.82	205.74	258.21	322.21	381.6
Book Value Per Share	22.12	12.55	15.81	13.57	15.88	18.01
Tangible Book Value	1,055	407.92	514.65	441.73	516.55	585.91
Tangible Book Value Per Share	22.12	12.53	15.81	13.57	15.87	18.00
Land	-	37.8	37.8	37.8	37.8	37.8
Buildings	-	70.52	70.52	70.52	70.52	70.52
Machinery	-	51.05	47.71	67.65	66.84	64.89

Source: S&P Global Market Intelligence. Standard template. Financial Sources.